GlaxoSmithKline (GSK -1.6%) says it plans to open an R&D facility in China to research...
Friday, September 7, 2012, 12:22 PM ETGlaxoSmithKline (GSK -1.6%) says it plans to open an R&D facility in China to research traditional Chinese medicine. The company will attempt to develop modern drugs based on the traditional treatments. Zang Jingwu, SVP and head of R&D China says "Traditional chinese medicine is a well-established system of medical practice developed through thousands of years of empirical testing and refinement of herbal mixtures, and relies generally on clinical experience."
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles